0
Signin
countryflagCA

888-969-2592

RY 156.04 -0.032% TD 79.81 -0.4615% SHOP 99.81 0.9303% CNR 158.79 0.6401% ENB 53.84 0.4478% CP 111.87 0.8019% BMO 112.71 0.7419% TRI 225.62 0.396% CNQ 50.46 2.4777% BN 67.8 1.194% ATD 76.93 -1.0674% CSU 4321.5298 0.3257% BNS 67.27 1.3102% CM 78.76 1.5603% SU 54.66 -1.1037% TRP 62.42 1.2162% NGT 70.54 0.2558% WCN 251.32 0.3153% MFC 36.65 -0.0818% BCE 47.21 0.3187%

Nova Leap Health Corp

Healthcare CA NLH

0.24CAD
-0.02(7.69%)

Last update at 2024-08-30T20:00:00Z

Day Range

0.240.26
LowHigh

52 Week Range

0.120.30
LowHigh

Fundamentals

  • Previous Close 0.26
  • Market Cap20.69M
  • Volume241500
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.46M
  • Revenue TTM26.41M
  • Revenue Per Share TTM0.31
  • Gross Profit TTM 9.98M
  • Diluted EPS TTM-0.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.20656M 2.47M 0.13M -0.95111M -1.04059M
Minority interest - - - - -
Net income -0.83574M 1.76M 1.26M -1.05581M -0.96127M
Selling general administrative 9.68M 7.58M 5.72M 5.34M 3.64M
Selling and marketing expenses - - - - -
Gross profit 9.98M 7.21M 5.87M 5.84M 3.32M
Reconciled depreciation 1.36M 0.86M 0.54M 0.62M 0.44M
Ebit -1.06211M -1.23138M -0.39608M -0.11283M -0.76374M
Ebitda 0.42M 3.74M 1.12M 0.13M -0.28494M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.06211M 3.89M 1.81M -0.11283M -0.76374M
Other operating expenses - - - - -
Interest expense 0.27M 0.40M 0.45M 0.46M 0.31M
Tax provision -0.37082M 0.71M -1.13078M 0.10M -0.07932M
Interest income - - - - 0.00000M
Net interest income -0.27099M -0.40112M -0.44812M -0.46073M -0.31292M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.37082M 0.71M -1.13078M 0.10M -0.07932M
Total revenue 28.21M 21.28M 17.31M 17.40M 10.36M
Total operating expenses 29.27M 17.39M 15.49M 17.52M 11.13M
Cost of revenue 18.23M 14.07M 11.44M 11.56M 7.04M
Total other income expense net 0.13M -1.01945M -1.24109M -0.37755M 0.04M
Discontinued operations - - - - -
Net income from continuing ops -0.83574M 1.76M 1.26M -1.05581M -0.96127M
Net income applicable to common shares -0.83574M 1.76M 1.26M -1.05581M -0.96127M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 23.95M 26.77M 17.54M 14.11M 12.46M
Intangible assets 1.09M 2.08M 1.35M 0.81M 0.99M
Earning assets - - - - -
Other current assets - - - - -
Total liab 5.27M 8.29M 7.69M 7.04M 5.70M
Total stockholder equity 18.68M 18.48M 9.84M 7.07M 6.76M
Deferred long term liab - - - - -
Other current liab 0.06M 0.43M 0.16M 0.19M 0.09M
Common stock 18.96M 17.14M 10.29M 9.00M 8.29M
Capital stock 18.96M 17.14M 10.29M 9.00M 8.29M
Retained earnings -1.19278M -0.35704M -2.11775M -3.37405M -2.30240M
Other liab - 0.14M 0.44M 0.20M 0.06M
Good will 16.04M 16.71M 10.18M 9.42M 8.21M
Other assets 1.35M 0.73M 1.28M 0.13M 0.20M
Cash 1.27M 1.73M 2.78M 1.64M 1.28M
Cash and equivalents - - - - -
Total current liabilities 3.99M 6.23M 4.17M 4.73M 5.07M
Current deferred revenue - - - - -
Net debt 1.20M 3.15M 2.80M 3.89M 3.34M
Short term debt - - - - -
Short long term debt 2.36M 3.99M 2.74M 3.48M 4.06M
Short long term debt total - - - - -
Other stockholder equity -1.21546M -0.08062M 0.09M 0.35M 0.52M
Property plant equipment 1.49M 1.29M 0.40M 0.27M 0.03M
Total current assets 3.98M 5.96M 4.33M 3.48M 3.03M
Long term investments - - - - -
Net tangible assets 1.55M -0.30411M -1.68386M -3.15307M -2.43347M
Short term investments - - - - -
Net receivables 2.41M 3.94M 1.41M 1.68M 1.49M
Long term debt 0.12M 0.90M 2.83M 2.04M 0.56M
Inventory - - - - -
Accounts payable 1.23M 1.31M 0.89M 0.82M 0.78M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 19.97M 20.81M 13.20M 10.63M 9.43M
Capital lease obligations 1.49M 1.32M 0.38M 0.19M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.05624M -7.40173M -1.56293M -0.99345M -6.35560M
Change to liabilities -0.06714M 0.36M 0.00439M 0.02M 0.47M
Total cashflows from investing activities -0.05624M -7.40173M -1.56293M -0.98830M -6.35560M
Net borrowings -2.92163M 0.19M -0.82661M 0.47M 3.02M
Total cash from financing activities -1.41358M 4.33M -0.32546M 0.73M 9.05M
Change to operating activities -0.26069M -0.39644M 0.37M 0.09M -0.21259M
Net income -0.83574M 1.76M 1.26M -1.05581M -0.96127M
Change in cash -0.46080M -1.04540M 1.14M 0.35M 1.15M
Begin period cash flow 1.73M 2.78M 1.64M 1.28M 0.14M
End period cash flow 1.27M 1.73M 2.78M 1.64M 1.28M
Total cash from operating activities 1.02M 2.18M 3.01M 0.59M -1.55021M
Issuance of capital stock 1.79M 4.38M - 0.00000M 6.19M
Depreciation 1.36M 0.86M 0.54M 0.62M 0.44M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - - - - -
Change to account receivables 0.42M -0.76307M 0.27M -0.19388M -1.21637M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.32964M -0.41968M -0.44777M -0.30557M 0.35M
Change to netincome 0.61M 0.15M 0.56M 1.11M -0.07351M
Capital expenditures 0.07M 0.07M 0.00672M 0.02M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.11042M -0.59627M 0.65M -0.07721M -0.95816M
Stock based compensation 0.36M 0.37M 0.31M 0.40M -
Other non cash items 0.24M 0.37M 0.43M 0.42M 0.31M
Free cash flow 0.95M 2.18M 3.01M 0.60M -1.56963M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NLH
Nova Leap Health Corp		 -0.02 7.69% 0.24 - 6.14 0.78 0.82 0.84 -129.1199
KDA
KDA Group Inc		 0.02 8.16% 0.27 - - 458.88 2.87 461.75 11.09
PHA
Premier Health of America Inc		 -0.01 5.88% 0.16 - 37.04 0.27 1.48 0.56 8.61
NPTH
NeuPath Health Inc		 0.005 2.86% 0.18 - 6.64 0.15 0.44 0.29 9.33
JNH
Jack Nathan Medical Corp		 -0.01 25.00% 0.03 - - 0.25 7.84 0.61 -1.8458

Reports Covered

Stock Research & News

View All

Profile

Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.

Nova Leap Health Corp

7071 Bayers Road, Halifax, NS, Canada, B3L 2C2

Key Executives

Name Title Year Born
Mr. Christopher Donald Dobbin C.A., CPA, CA, CPA CEO, Pres & Director 1975
Ms. Megan Spidle CPA, C.A. CFO & Corp. Sec. 1977
Ms. Alison DeBlois VP of Operations (U.S.) NA
Mr. Michael Gremley Mang. of Corp. Devel. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.